Related Experiment Video
Updated: Aug 6, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Aortic valve replacement for aortic stenosis after previous coronary artery bypass grafting: could early reoperation
Jean Ph Verhoye1, Franceseca Merlicco, Ibrahim M Sami
1Department of Thoracic and Cardiovascular Surgery, University Hospital, Ponchaillou, Rennes, France. jean-philippe.verhoye@chu-rennes.fr
Insights
Aortic valve replacement (AVR) after coronary artery bypass graft (CABG) surgery carries high mortality if performed within five years. Consider AVR during CABG for select patients to improve outcomes.
Area of Science:
- Cardiovascular Surgery
- Cardiac Valve Disease
- Aortic Stenosis Management
Background:
- Coronary artery bypass graft (CABG) surgery is often performed in patients with concomitant aortic stenosis (AS).
- The optimal timing for aortic valve replacement (AVR) in patients who have undergone prior CABG is not well-defined.
- Previous studies have not fully elucidated the risks associated with accelerated AS progression and outcomes after AVR in this patient cohort.
Purpose of the Study:
- To retrospectively investigate the risk of accelerated aortic stenosis (AS) progression.
- To evaluate the outcomes following aortic valve replacement (AVR) in patients with prior coronary artery bypass graft (CABG) surgery.
- To identify predictors for AVR within five years of CABG.
Main Methods:
- Retrospective analysis of 81 patients who underwent AVR for mild-to-moderate AS after initial CABG between 1994 and 2004.
- Patients were stratified into three groups based on the time interval between CABG and AVR: <5 years, 5-10 years, and >10 years.
- Multivariate analysis was employed to identify independent predictors of AVR timing and operative mortality.
Main Results:
- Overall operative mortality after AVR was 16%, with significantly higher rates (30%) in patients undergoing AVR within five years of CABG.
- Independent predictors for AVR within five years included a peak transvalvular gradient ≥30 mmHg, moderate calcifications with limited valve motion, and left ventricular hypertrophy (LVH).
- Systemic vascular atherosclerotic disease predicted rapid AS progression and was a predictor of operative mortality.
Conclusions:
- Due to high mortality associated with early repeat operations, AVR should be considered concurrently with CABG in select patients.
- Recommended patient profile for concurrent AVR includes age ≤75 years, peak transvalvular gradient >30 mmHg, moderate calcifications with limited valve motion, and LVH.
- This approach may mitigate risks associated with accelerated AS progression and improve long-term outcomes in patients requiring both procedures.
Background And Aim Of The Study:
The study aim was to examine, retrospectively, the risk of accelerated progression of aortic stenosis (AS) and outcome after aortic valve replacement (AVR) in patients who had undergone previous coronary artery bypass graft (CABG) surgery.
Methods:
Between 1994 and 2004, 81 patients with mild-to-moderate AS at the time of CABG underwent subsequent AVR. The mean EuroScore was 10.8 +/- 1.8. The population was divided into three subgroups according to the time interval between AVR and CABG: group A, < 5 years (n = 23); group B, 5-10 years (n = 34); and group C, > 10 years (n = 24).
Results:
Mean age at the time of CABG was 70 +/- 5, 64 +/- 6 and 58 +/- 5 years in groups A, B, and C, respectively. The peak transvalvular gradient was < or = 30 mmHg in 65 patients (80.2%), and 30-50 mmHg in 16 (19.7%). Operative mortality after AVR was 16% in the overall population (30%, 11.7%, and 8.6% in groups A, B, and C, respectively). The mean time interval between CABG and AVR was 8.9 +/- 5.2 years. By multivariate analysis, a peak transvalvular gradient > or = 30 mmHg (p = 0.003), moderate calcifications with moderately-to-severely limited valve motion (p = 0.05), and left ventricular hypertrophy (LVH) (p = 0.005) were independent predictors of AVR within five years of CABG surgery. Systemic vascular atherosclerotic disease was a predictor of rapid disease progression by univariate analysis, and a predictor of operative mortality by multivariate analysis.
Conclusion:
Because of the high mortality associated with repeat operations within five years, AVR should be considered at the time of CABG in patients aged < or = 75 years, with a peak transvalvular gradient > 30 mmHg, moderately prominent calcifications with moderately to severely limited valve motion, and LVH.
More Related Videos
Related Concept Videos
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Coronary Artery Disease V: Interprofessional Care
Aortic Regurgitation I: Introduction
Aneurysm III: Interprofessional Care
Aneurysm IV: Nursing Management

